Table 4 Average cost-effectiveness results from probabilistic sensitivity analyses
ICER per life saved | ICER per QALY gained | ICER per DALY averted | |
|---|---|---|---|
Status quo | NA | NA | NA |
Scenario 1: 100% testing rate | 18 (14–19) | 17 (13–22) | 13 (12–18) |
Scenario 2: Increase testing rate by 10% | 13 (10–14) | 13 (10–20) | 10 (9–13) |
Scenario 3: 100% treatment rate | 462 (393–754) | 640 (626–636) | 502 (405–741) |
Scenario 4: Increase treatment rate by 10% | 81 (75–107) | 105 (91–108) | 87 (73–100) |
Scenario 5: 1 and 3 | 21 (19–23) | 21 (18–26) | 30 (25–47) |
Scenario 6: 2 and 4 | 35 (12–56) | 36 (9–100) | 28 (9–74) |